Elasmogen Ltd
Elasmogen is a therapeutic biologics company developing dual targeting products for difficult-to-treat immune-mediated diseases. Our lead, first-in-class product, ELN28, is designed to target to the site of inflammation where it neutralises soluble TNFa whilst specifically and safely delivering Janus kinase inhibitor. Our mission is to clinically advance ELN28, positioning it as a truly transformative therapy for Hidradenitis Suppurativa.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
70
organic / mo
Sign up free to see all 7 verified contacts at Elasmogen Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- OC
Obinna C Ubah
Principal Scientist Programme Lead · Other
EmailPhone - EM
Euan Murray
Senior Scientist · Research & Development
EmailPhone - SP
Stella Priyanka
Senior Research Scientist · Research & Development
EmailPhone - AP
Andy Porter
Director - Chief Technical Officer · Information Technology
EmailPhone
Showing 4 of 7 verified contacts
Top roles at Elasmogen Ltd
5 distinct titles indexed · top 5 shown.
- 2research scientist
- 2senior scientist
- 1director - chief technical officer
- 1principal scientist programme lead
- 1senior research scientist
Sign up to unlock all 7 contacts at Elasmogen Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Elasmogen Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.